EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Topics of Progressive Cardiac Conduction Disease

Naokata Sumitomo iD, Hitoshi Mori iD, Takashi Kumamoto iD, Taisuke Ishikawa, Akiko Seki iD, Naomasa Makita iD, Jean-Jacques Schott iD, Arthur A M Wilde iD

Journal of Arrhythmia · 2026-06 · 42 (3)

DOI: 10.1002/joa3.70383 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Arrhythmia, online erschienen am 25.06.2026. Verfasst von Naokata Sumitomo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Cardiology Saitama Medical University International Medical Center Saitama Japan. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Progressive cardiac conduction disease (PCCD) is a rare inheritable cardiac conduction system disease that may lead to complete heart block, syncope, or sudden cardiac death. The estimated incidence of PCCD is 0.0005%/year. Recent advances in genetics have revealed a wide variety of diseases associated with the development of PCCD. Ion channel genes ( SCN5A, KCNK17, TRPM4, HCN4 ), gap junction genes ( GJA5 , GJC1 ), genes associated with myopathy ( LMNA , EMD , DES , DMD , TNNI3K , DMPK, ZNF9 ), transcription factor genes ( NKX2‐5 , TBX5 ), genes associated with metabolic disease ( PRKAG2 , LAMP2 , GLA ), and mitochondrial gene variants have all been associated with the occurrence of PCCD. Pacemaker implantation is the first‐line therapy for PCCD, but implantable cardioverter defibrillator implantation should be considered in some cases. This review aims to provide a clinically relevant overview of these different forms, with emphasis on their genetic basis and phenotypic expression. We propose a practical classification distinguishing isolated and associated forms of PCCD and discuss the implications for diagnosis, risk stratification, and patient management.

Schlagwörter

Stichwörter der Autor:innen

implantable cardioverter defibrillatorinherited arrhythmiapacemaker implantationprogressive cardiac conduction diseasesudden cardiac death

Autor:innen und Institutionen

  • Department of Pediatric Cardiology Saitama Medical University International Medical Center Saitama Japan.
  • Department of Cardiology Saitama Medical University International Medical Center Saitama Japan.
  • Department of Pediatrics Saga University Saga Japan.
  • Veterinary Teaching Hospital, Joint Faculty of Veterinary Medicine Kagoshima University Kagoshima Japan.
  • Department of Cardiology Tokyo Women's Medical University Tokyo Japan.
  • Department of Preventive Medicine Tokyo Women's Medical University Tokyo Japan.

ORCID-Profile: Naokata Sumitomo, Hitoshi Mori, Takashi Kumamoto, Akiko Seki, Naomasa Makita, Jean-Jacques Schott, Arthur A M Wilde

Zitieren

APA

Sumitomo, N., Mori, H., Kumamoto, T., Ishikawa, T., Seki, A., Makita, N., Schott, J. J., & Wilde, A. A. M. (2026). Current Topics of Progressive Cardiac Conduction Disease. Journal of Arrhythmia, 42(3). https://doi.org/10.1002/joa3.70383

Vancouver

Sumitomo N, Mori H, Kumamoto T, Ishikawa T, Seki A, Makita N, et al. Current Topics of Progressive Cardiac Conduction Disease. Journal of Arrhythmia. 2026;42(3). doi:10.1002/joa3.70383

BibTeX
@article{Sumitomo2026,
  author = {Sumitomo, Naokata and Mori, Hitoshi and Kumamoto, Takashi and Ishikawa, Taisuke and Seki, Akiko and Makita, Naomasa and Schott, Jean-Jacques and Wilde, Arthur A M},
  title = {Current Topics of Progressive Cardiac Conduction Disease},
  journal = {Journal of Arrhythmia},
  year = {2026},
  volume = {42},
  number = {3},
  doi = {10.1002/joa3.70383}
}
Kostenlos starten →